You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

DEXTROMETHORPHAN POLISTIREX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Dextromethorphan Polistirex, and what generic alternatives are available?

Dextromethorphan Polistirex is a drug marketed by Amneal and Tris Pharma Inc and is included in two NDAs.

The generic ingredient in DEXTROMETHORPHAN POLISTIREX is dextromethorphan polistirex. There are twenty-three drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the dextromethorphan polistirex profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Dextromethorphan Polistirex

A generic version of DEXTROMETHORPHAN POLISTIREX was approved as dextromethorphan polistirex by TRIS PHARMA INC on May 25th, 2012.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DEXTROMETHORPHAN POLISTIREX?
  • What are the global sales for DEXTROMETHORPHAN POLISTIREX?
  • What is Average Wholesale Price for DEXTROMETHORPHAN POLISTIREX?
Summary for DEXTROMETHORPHAN POLISTIREX
Drug patent expirations by year for DEXTROMETHORPHAN POLISTIREX
Medical Subject Heading (MeSH) Categories for DEXTROMETHORPHAN POLISTIREX
Paragraph IV (Patent) Challenges for DEXTROMETHORPHAN POLISTIREX
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
DELSYM Extended-release Suspension dextromethorphan polistirex 30 mg/5 mL 018658 1 2009-01-12

US Patents and Regulatory Information for DEXTROMETHORPHAN POLISTIREX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal DEXTROMETHORPHAN POLISTIREX dextromethorphan polistirex SUSPENSION, EXTENDED RELEASE;ORAL 203133-001 Jul 28, 2017 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Tris Pharma Inc DEXTROMETHORPHAN POLISTIREX dextromethorphan polistirex SUSPENSION, EXTENDED RELEASE;ORAL 091135-001 May 25, 2012 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.